Human AdjustLtd Valuation

Is 249A undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 249A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 249A's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 249A's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 249A?

Key metric: As 249A is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 249A. This is calculated by dividing 249A's market cap by their current earnings.
What is 249A's PE Ratio?
PE Ratio18.9x
EarningsJP¥27.00m
Market CapJP¥510.00m

Price to Earnings Ratio vs Peers

How does 249A's PE Ratio compare to its peers?

The above table shows the PE ratio for 249A vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.6x
6029 Artra Group
21.9xn/aJP¥1.3b
7090 Ligua
16.8xn/aJP¥1.6b
189A D & M Company
10.9xn/aJP¥1.9b
9214 Recovery InternationalLtd
20.7xn/aJP¥1.9b
249A Human AdjustLtd
18.9xn/aJP¥510.0m

Price-To-Earnings vs Peers: 249A is expensive based on its Price-To-Earnings Ratio (18.9x) compared to the peer average (17.5x).


Price to Earnings Ratio vs Industry

How does 249A's PE Ratio compare vs other companies in the JP Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
249A 18.9xIndustry Avg. 13.8xNo. of Companies9PE0816243240+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 249A is expensive based on its Price-To-Earnings Ratio (18.9x) compared to the JP Healthcare industry average (13.8x).


Price to Earnings Ratio vs Fair Ratio

What is 249A's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

249A PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio18.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 249A's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies